Henry Friedman MD

Professor of Neuro-Oncology, Duke University

2100 Erwin RdDurham, NC 27705
Phone+1 919-620-4467
Fax+1 919-684-6674

Dr. Friedman is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Friedman's full profile Already have an account?

Summary

Dr. Henry Friedman is a neurosurgeon specializing in neuro-oncology and pediatric neuro-oncology, based in Durham, NC. He completed his medical education and fellowships in hematology, medical oncology, and pediatric hematology/oncology at SUNY Upstate Medical University and Duke University Hospital. Holding the position of James B. Powell, Jr. Professor of Neuro-oncology at Duke University Hospital since 1983, his work includes numerous clinical trials focusing on glioma treatment. Dr. Friedman has published extensively on topics such as peptides in cancer treatment and chemotherapy-induced nausea. His honors include recognition in America's Top Doctors for Cancer and several CMS Meaningful Use Certifications from Epic Systems Corporation.

Education & Training

Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1981 - 1983
SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 1979 - 1980
SUNY Upstate Medical UniversityResidency, Pediatrics, 1977 - 1979
SUNY Upstate Medical UniversityClass of 1977

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NC State Medical License 1983 - 2027
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors for Cancer Castle Connolly
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2015, 2017
CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014-2015, 2017

Clinical Trials

Carboplatin in Patients With Progressive Gliomas Start of enrollment: 1993 Feb 01
Completed
Phase 2
Melphalan in Patients With Neoplastic Meningitis Start of enrollment: 1992 Dec 01
Completed
Phase 1
Chemotherapy in Treating Patients With Recurrent Malignant Glioma Start of enrollment: 1997 Feb 01
Completed
Phase 1

Publications & Presentations

PubMed

Clinical trial of feasibility for mindfulness intervention for patients with newly diagnosed high grade glioma.
Kavya Ramamurthy, Dina M Randazzo, Nicole Cort, James E Herndon 2nd, Evan Buckley
Journal of Neuro-Oncology. 2025-11-05
6 citations
A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8infiltration in glioma.
Kirit Singh, Matthew W Foster, Marlene J Violette, Anna M Corcoran, Kelly M Hotchkiss
Scientific Reports. 2025-10-23
8 citations
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial.
Eric M Thompson, David M Ashley, Katayoun Ayasoufi, Pamela Norberg, Gerald Archer
Nature Cancer. 2025-09-01

Journal Articles

The Genomic Landscape of TERT Promoter Wildtype-IDH Wildtype Glioblastoma
Daniel B. Loriaux, Darel D. Bigner, Fausto J. Rodriguez, Hai Yan, Bil H. Diplas, Henry S. Friedman, Roger E. McLendon, Nature